HOME >> MEDICINE >> NEWS
Enzyme linked to mania and schizophrenia impairs higher brain functions

Overactivity of protein kinase C (PKC), an enzyme that is implicated in bipolar disorder and schizophrenia, markedly impairs higher brain functions in animals, according to a Yale study published Oct. 29 in Science.

The research adds to mounting evidence that excessive activity of PKC may underlie the distractibility, impaired judgment, impulsivity, and disturbed thinking seen in bipolar disorder (also known as manic depressive illness), and in schizophrenia.

The study also shows that exposure to mild stress can activate PKC, which may lead to worsening of symptoms in patients with these disorders. The findings may explain how upsetting events in the environment can lead to deterioration in higher brain function, and why patients with schizophrenia or bipolar disorder may be particularly susceptible to stress-induced dysfunction. PKC inhibitors may be useful in treating these illnesses, according to Amy Arnsten, associate professor, Department of Neurobiology at Yale School of Medicine and senior author of the study.

"These new findings may also help us understand the impulsivity and distractibility observed in children with lead poisoning," Arnsten said. "Very low levels of lead can activate PKC, and this may lead to impaired regulation of behavior."

Recent genetic and biochemical studies indicate that bipolar disorder and schizophrenia are associated with overactivity of PKC, and many medications that treat schizophrenia and bipolar disorder reduce PKC activity. However, the link between PKC overactivity and neuropsychiatric symptoms had not been understood.

This study examined the effects of increasing PKC activity in the prefrontal cortex of animals performing working memory tasks. The prefrontal cortex is a brain region that allows for the regulation of thoughts, behaviors and feelings. The prefrontal cortex becomes dysfunctional in both bipolar disorder and schizophrenia. In animals, either direct or indirect act
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
28-Oct-2004


Page: 1 2

Related medicine news :

1. Enzyme prevents lung damage in premature infants
2. Enzyme found in blood vessels likely target to treat lung injury
3. Enzyme structure holds key to cocaine, heroin metabolism
4. Enzyme replacement therapy found to effectively treat patients with Fabry disease
5. Enzyme level linked to death after angioplasty
6. Enzyme halts muscle waste in mouse models of most-common childhood muscular dystrophy
7. Enzyme could provide continual fat burning
8. Study finds factors linked to substance use disorder relapse among health care professionals
9. Depression linked to insomnia in HIV patients
10. Abuse and HIV status linked to suicide risk
11. Waist size linked to diabetes risk in adult men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the University of California Berkeley, and other leading institutions in announcing the launch ... of institutions to change the way animals are raised for food. , Founding ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... YORK , Sept. 12, 2017   EcoVadis , the leading ... has published the first annual edition of its Global CSR Risk and ... companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 ... ... Index ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical ... independent supplier of medical equipment, supplies, drugs, vaccines, and ... has entered into an agreement to acquire Vantage Medical ... based in Holtsville, New York . ... in supplying new and emerging medical practices, will operate ...
Breaking Medicine Technology:
Cached News: